Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin for treatment of COVID-19 pneumonia
IRCT20190624043993N2Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in coronavirus disease 2019 (COVID-19) comparing Ivermectin plus standard of care with Standard of care (2 arms). Primary endpoints: Clinical response, Virological recovery and 3 more. Started Aug 2020; status: completed.
02
Drugs
ivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20190624043993N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190624043993N2.